Tags

Type your tag names separated by a space and hit enter

Quality control of intensified insulin therapy: HbA1 versus blood glucose.
Horm Metab Res 1994; 26(12):574-8HM

Abstract

Since the measurement of HbA1 has become available to the diabetologists, the physicians and patients tend to rely exclusively on this parameter for the assessment of metabolic control. Therefore, in this study, 24 hour glucose profiles of 8 selected patients (4 under intensified conventional therapy, ICT, and 4 under continuous subcutaneous insulin infusion, CSII) with HbA1 values indicating good metabolic control were taken three times at four week intervals and were compared to mean blood glucose (MBG), mean average of glucose excursions (MAGE) and Schlichtkrull's M-value. MBG of the 24 profiles was 114 +/- 21 mg/dl. The patients under CSII were somewhat lower than the patients under ICT. In 16 of the 24 profiles, there was at least one period of hypoglycemia of 50 mg/dl and below. Only in one patient, M-value and MAGE showed stable metabolic control. In conclusion, hyperglycemic excursions in patients under intensified conventional therapy or treated by continuous subcutaneous insulin infusion do escape their reflection in the HbA1 values because of low blood sugar periods following hyperglycemic swings. Undoubtedly, the partial failure of ICT and CSII to prevent diabetic complications might be ascribed to the incomplete assessment of the metabolic control based on HbA1 values exclusively.

Authors+Show Affiliations

Institut für Diabetes-Technologie an der Universität Ulm, Germany.No affiliation info availableNo affiliation info available

Pub Type(s)

Clinical Trial
Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

7705761

Citation

Bischof, F, et al. "Quality Control of Intensified Insulin Therapy: HbA1 Versus Blood Glucose." Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme, vol. 26, no. 12, 1994, pp. 574-8.
Bischof F, Meyerhoff C, Pfeiffer EF. Quality control of intensified insulin therapy: HbA1 versus blood glucose. Horm Metab Res. 1994;26(12):574-8.
Bischof, F., Meyerhoff, C., & Pfeiffer, E. F. (1994). Quality control of intensified insulin therapy: HbA1 versus blood glucose. Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme, 26(12), pp. 574-8.
Bischof F, Meyerhoff C, Pfeiffer EF. Quality Control of Intensified Insulin Therapy: HbA1 Versus Blood Glucose. Horm Metab Res. 1994;26(12):574-8. PubMed PMID: 7705761.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Quality control of intensified insulin therapy: HbA1 versus blood glucose. AU - Bischof,F, AU - Meyerhoff,C, AU - Pfeiffer,E F, PY - 1994/12/1/pubmed PY - 1994/12/1/medline PY - 1994/12/1/entrez SP - 574 EP - 8 JF - Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme JO - Horm. Metab. Res. VL - 26 IS - 12 N2 - Since the measurement of HbA1 has become available to the diabetologists, the physicians and patients tend to rely exclusively on this parameter for the assessment of metabolic control. Therefore, in this study, 24 hour glucose profiles of 8 selected patients (4 under intensified conventional therapy, ICT, and 4 under continuous subcutaneous insulin infusion, CSII) with HbA1 values indicating good metabolic control were taken three times at four week intervals and were compared to mean blood glucose (MBG), mean average of glucose excursions (MAGE) and Schlichtkrull's M-value. MBG of the 24 profiles was 114 +/- 21 mg/dl. The patients under CSII were somewhat lower than the patients under ICT. In 16 of the 24 profiles, there was at least one period of hypoglycemia of 50 mg/dl and below. Only in one patient, M-value and MAGE showed stable metabolic control. In conclusion, hyperglycemic excursions in patients under intensified conventional therapy or treated by continuous subcutaneous insulin infusion do escape their reflection in the HbA1 values because of low blood sugar periods following hyperglycemic swings. Undoubtedly, the partial failure of ICT and CSII to prevent diabetic complications might be ascribed to the incomplete assessment of the metabolic control based on HbA1 values exclusively. SN - 0018-5043 UR - https://www.unboundmedicine.com/medline/citation/7705761/abstract/Quality_control_of_intensified_insulin_therapy:_HbA1_versus_blood_glucose_ L2 - http://www.thieme-connect.com/DOI/DOI?10.1055/s-2007-1001762 DB - PRIME DP - Unbound Medicine ER -